Delivery Order SPE2DB22D3301-SPE2DB24FX9ZE

Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $5.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,692.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order for the pharmaceutical product levothyroxine 200 mcg/5 ml vial, 5 ml, with a completion date of November 23, 2021. The contract is a firm fixed-price (FFP) arrangement, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order valued at $1,945.20 for the supply of 4,564,085,692 units of 100 mcg/5 ml vial of levothyroxine. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and also holds an Indefinite Delivery Contract (IDC) with DLA valued at...
This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) for the supply of 4,566,076 vials of 500 mcg Levothyroxine, a thyroid medication. The contract is a firm-fixed price arrangement with a ceiling value of $6,825.18 and an ultimate completion date of October 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FDVC0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,797.52 firm fixed-price delivery order is for the supply of 4566985479 Levothyroxine 100 mcg vials. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of Levothyroxine 100 mcg vials. The contract has a ceiling value of $1,549.20 and runs through February 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary vehicle for...
This federal contract award is for the delivery of Levothyroxine 50 MCG capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by the parent company Cencora, Inc. The award has a ceiling value of $1,285.10 and a completion date of December 4, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating full and...
The Defense Logistics Agency (DLA) awarded a $1,092.69 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,189,790 units of 112 mcg Levothyroxine tablets. This contract, with an ultimate completion date of December 28, 2023, is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying a wide range of medical products, including specialty medications,...
This federal contract award is for the delivery of Levothyroxine 150mcg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $1,484.01, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm fixed-price delivery order contract with no set-aside designation,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,555.90 firm fixed-price contract is for the delivery of 4,563,268 units of the prescription drug Levothyroxine 175 mcg capsules. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,242.71 and is for the delivery of 4,563,017,653 units of the prescription drug Levothyroxine 50 MCG Tablet. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FX9ZE
    Delivery Order

This federal contract award, valued at $5,677.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Levothyroxine 500 MCG vials, a critical pharmaceutical product. This is a firm fixed-price Delivery Order contract with a completion date of February 5, 2024. The contract was awarded on February 2, 2024 and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a significant role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract.

Generated 5/14/25, 9:59 AM